Biotech / MedTech

Hong Kong-based biotech firm Immuno Cure BioTech (Immuno Cure) announced Thursday that it has closed the $12 million tranche in the $27 million Series A fundraising round. Led by the AEF Greater Bay Area Fund that Gobi Partners GBA (Gobi GBA) manages, this round will be used to accelerate the development of DNA vaccines and antibodies, as well as to prepare…

The company has raised over $2 million from 500 Global, TOP Ventures (CVC-arm of Thai Oil PLC) and angel investors—from a group of former executives of Coca-Cola, PepsiCo and Dole, to a family office of one of the largest healthcare networks in Southeast Asia.

Mirxes Holding Company Limited, a Singapore-headquartered biotech firm, announced Tuesday that it has filed listing application with The Stock Exchange of Hong Kong Limited after securing $50 million Series D funding.

Singapore home-grown biotechnology start up Ento Industries has secured growth funding from a pair of environmental, social and governance (ESG)-focused private investors Tak Wai CHUNG and Te-LingNAI. The funding will expedite the firm's move to a larger facility and ramp up its production capabilities.

BLUU Seafood, a Germany-based food biotech that produces cultivated fish, aims to launch the first cultivated seafood products in Singapore in 2024 after securing Series A funding. After securing EUR 16 million ($17.36 million), the firm has secured the necessary capital to further advance the work on its groundbreaking technology and to enable the market…

Apeiron Bioenergy (Apeiron), a Singapore-based integrated global player in bioenergy, has raised SGD 50 million ($36.95 million) through the landmark issuance of a five-year senior unsecured green bond guaranteed by Credit Guarantee and Investment Facility (CGIF), a trust fund of the Asian Development Bank.

In the interview ahead of the company’s de-SPAC, CEO also shared about the challenges and opportunities as the precision oncology space, the company's immediate plan following its listing. He also shared his views on the biotech landscape in Southeast Asia and gave several suggestions for for companies, governments, and investors for the biotech industry in…

PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures.

Azeem is one of the speakers at the DLD Conference held between January 12 and 14 in Munich, Germany.

Alio, Inc., a United States-based medical technology company reinventing the management of chronic disease, announced it has raised $18 million in the initial close of a Series C financing, bringing the total amount the company has raised to over $50 million. The financing was led by the Widjaja Family Investment Office with participation from the company’s…